Navigation Links
Matrixx Initiatives, Inc. and H.I.G. Capital Announce Early Termination of HSR Waiting Period
Date:12/29/2010

ubject to certain conditions as described in the tender offer statement on Schedule TO filed with the Securities and Exchange Commission (the "SEC") on December 22, 2010. 

Under the terms of the merger agreement, Matrixx may solicit acquisition proposals from third parties until 11:59 p.m., New York City time, on Saturday, January 22, 2011. The Company's financial advisor, Sawaya Segalas & Co., LLC, is assisting the Company's board of directors in connection with the solicitation. It is not anticipated that any developments will be disclosed with regard to this process unless the Company's board of directors makes a decision with respect to a potential superior proposal. There are no guarantees that this process will result in a superior proposal.

About Matrixx Initiatives, Inc.

Matrixx Initiatives, Inc. is an over-the-counter healthcare company that develops and markets Zicam® products. Zicam, LLC, its wholly-owned subsidiary, markets and sells Zicam® products in the cough and cold category. The Company markets Zicam brand pharmaceuticals, including Zicam Cold Remedy in multiple oral delivery forms; Zicam Allergy and Congestion Relief products; as well as Zicam Cough and Zicam Multi-Symptom relief items. For more information regarding Matrixx products, go to www.Zicam.com. To find out more about Matrixx Initiatives, Inc. (Nasdaq: MTXX), visit our website at www.matrixxinc.com. For additional information, contact William Hemelt, President and Chief Executive Officer, at 602-385-8888, or Bill Barba, Vice President of Finance & Accounting, at 602-385-8881. Matrixx is located at 8515 E. Anderson Dr., Scottsdale, Arizona 85255.

About H.I.G. Capital

H.I.G. Capital is a leading global private equity investment firm with more than
'/>"/>

SOURCE Matrixx Initiatives, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Matrixx Initiatives, Inc. Sets Time for Discussion of Fiscal 2011 Second Quarter Financial Results
2. Matrixx Initiatives, Inc. Sets Time for Discussion of Fiscal 2011 First Quarter Financial Results
3. Matrixx Initiatives, Inc. Sets Time for Discussion of Fourth Quarter and Fiscal 2010 Financial Results
4. Matrixx Initiatives, Inc. Sets Time for Discussion of Third Quarter Fiscal 2010 Financial Results
5. Huntsman Gay-Led Consortium Completes Recapitalization of Sunquest Information Systems
6. Poniard Pharmaceuticals Announces Plan for Voluntary Prepayment of Term Loan and Transfer to Nasdaq Capital Market
7. WaferGen Announces $7 Million Capital Raise -- $5 Million Equity Private Placement Agreement Signed, and $2 Million Credit Facility Closed
8. NeoStem Announces Agreement With Shijiazhuang Third Hospital in the Provincial Capital of Hebei Province, China to Offer Orthopedic Applications Based on NeoStem’s Licensed Technology
9. Solos Endoscopy, Inc. Announces Recapitalization Plan for 2011
10. Quest Diagnostics to Speak at the Lazard Capital Markets 7th Annual Healthcare Conference
11. Medco to Present at the Lazard Capital Markets 7th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... and NEW YORK , Sept. ... SAS and the Hereditary Neuropathy Foundation (HNF) announced today ... awareness around Charcot-Marie-Tooth (CMT) disease and support the development ... Pharnext will provide financial support to several ... development of a specific section in the HNF website ...
(Date:9/15/2014)... 2014 /PRNewswire/ -  Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ... with a focus on Omega-3 therapies for cardiovascular ... Board of Directors approved the granting of stock ... close of business on Friday, September 12, 2014. ... shares of the Company were granted in accordance ...
(Date:9/15/2014)...  Valeant Pharmaceuticals International, Inc. (NYSE: VRX ... Valeant Pharmaceuticals International, will redeem all of the outstanding ... Notes due 2017, CUSIP Nos. 91911XAL8, U9098VAD4 (the " ... an irrevocable notice of redemption for the Notes. ... irrevocable notice of redemption with respect to the remaining ...
Breaking Medicine Technology:Pharnext and the Hereditary Neuropathy Foundation Collaborate to Increase Awareness of Charcot-Marie-Tooth Disease 2Pharnext and the Hereditary Neuropathy Foundation Collaborate to Increase Awareness of Charcot-Marie-Tooth Disease 3Pharnext and the Hereditary Neuropathy Foundation Collaborate to Increase Awareness of Charcot-Marie-Tooth Disease 4Pivotal Therapeutics Grants Incentive Stock Options 2Valeant Announces Redemption of All of the Outstanding $500.0 Million Aggregate Principal Amount of its 6.75% Senior Notes due 2017 2
... , , JERUSALEM, Israel, January 11 ... systems, today announced that it has filed two registration,statements on ... One registration statement relates to a proposed ... and warrants to purchase 12,million shares of common stock, as ...
... , SAN JOSE, Calif., Jan. 11 Finesse Solutions, ... life sciences process applications, announced the production release of ... oxygen or pH and process temperature, and TruTorr headspace ... accuracy, lifetime, and ease of use. It is available ...
Cached Medicine Technology:Oramed Pharmaceuticals Announces Filing of Two Registration Statements 2Oramed Pharmaceuticals Announces Filing of Two Registration Statements 3Single-Use Sensor Product Family Enters High Volume Production 2
(Date:9/16/2014)... (PRWEB) September 16, 2014 Synergy Research ... comprehensive report gives the best detail and analysis of ... pulled from a variety of sources, including Ministry of ... Orange Paper will give readers actionable intelligence on clinical ... Paper is relied on by the local and international ...
(Date:9/16/2014)... Florida Hospital announced today it is teaming up ... and become the Presenting Sponsor of the 2014-15 and ... and wellness partner. As the Presenting Sponsor for the ... and name inclusion on all Lightning advertising campaigns and ... been a sponsorship partner of the Lightning since 2011, ...
(Date:9/16/2014)... Whatisfinalexpenseinsurance.com has released a new ... life insurance for seniors. , Finding affordable life insurance ... big part of the insurance market has moved online. ... that clients can use when shopping for life coverage. ... important for providing financial security for vulnerable family members. ...
(Date:9/16/2014)... serve of dairy food may reduce the risk of ... foods have not traditionally formed part of the diet. ... by Emeritus Professor Mark Wahlqvist from Monash University,s Department ... Institute, considered the role increased consumption of dairy foods ... longevity. , "In a dominantly Chinese food culture, ...
(Date:9/16/2014)... 15, 2014A comparison of five-year sexual function ... external beam radiotherapy (EBRT) versus combination EBRT ... vessel-sparing radiation therapy makes cure possible without ... presented today at the American Society for ... , The study examined the patient-reported outcomes ...
Breaking Medicine News(10 mins):Health News:Synergy Research Group Debuts Ukraine Orange Paper 2Health News:Florida Hospital Teams up with the Tampa Bay Lightning as the New Presenting Sponsor of the 2014-15 and 2015-16 Lightning Seasons 2Health News:Florida Hospital Teams up with the Tampa Bay Lightning as the New Presenting Sponsor of the 2014-15 and 2015-16 Lightning Seasons 3Health News:Life Insurance for Seniors - Clients Can Find Fast Life Insurance By Comparing Online Quotes! 2Health News:A heart-felt need for dairy food 2Health News:Prostate cancer patients surveyed 5 years after vessel-sparing RT report preserved sexual function 2Health News:Prostate cancer patients surveyed 5 years after vessel-sparing RT report preserved sexual function 3
... and longevity to health status and quality of life. Researchers ... longer, but the quality of life in later years must// ... benefits of staying physically active in your later years. The ... to perform their daily activities easier later in life. ...
... for a cure for diabetes. A new study done in ... insulin producing //pancreatic islet cells. This could lead to a ... research is a follow up to the 2001 report of ... The new research focuses on the biological mechanism behind that ...
... a deterioration of the retina, is the number one cause ... significantly // reduce the number of people with vision loss ... ,A couple of years ago, researchers conducted a ... vitamins C, E, and beta carotene, along with zinc oxide ...
... lifestyle changes and medication can prevent or delay the onset ... used to identify high-risk individuals for diabetes, but the test ... of risk //factors known as metabolic syndrome is able to ... ,Metabolic syndrome has been shown to lead to the ...
... eat play a role in whether you’ll end up with ... women between //ages 20 and 40 for one year. Their ... at least eight servings of fruits or vegetables a day ... than those who ate their usual diets. ,The ...
... a historic vote Friday night on a bill that would ... // of the politically popular entitlement program in its 38-year ... have lined up in our favor," House Speaker Dennis Hastert ... time is upon us. It's now or never." ...
Cached Medicine News:Health News:Predictors for Type 2 Diabetes 2Health News:House heads for Medicare drug vote, 2Health News:House heads for Medicare drug vote, 3
... onsite test! QuickScreen multi-panel dip cards offer ... your choice of any conceivable combination of ... flexibility for your drug testing program. Just ... the built-in timer tells you when to ...
... Screen Tests are available in 14 configurations ... Designed using Microgenics Antibody Technology, the SureStep™ ... of care immunoassay targeted to detect MDMA ... and MDEA but no cross-reactivity to any ...
Accu-Stat Home Drug Test for Marijuana (THC), Cocaine (COC), Amphetamine (AMP), Methamphetamine (mAMP), Opiates (OPI), and Phencyclidine (PCP)....
... are highly accurate in detecting the presence of ... by GC/MS testing. This assay provides a preliminary ... as GC/MS) must be used in order to ... applied to any drug of abuse test result, ...
Medicine Products: